Pharmaron Beijing Co., Ltd. (SHE:300759)
China · Delayed Price · Currency is CNY 34.05
+2.08 (6.51%)
Oct 29, 2025, 3:04 PM CST
Pharmaron Beijing Market Cap
Pharmaron Beijing has a market cap or net worth of 56.99 billion as of October 29, 2025. Its market cap has increased by 58.44% in one year.
Market Cap
56.99B
Enterprise Value
61.67B
Revenue
13.54B
Ranking
n/a
PE Ratio
39.77
Stock Price
34.05
Market Cap Chart
Since January 28, 2019, Pharmaron Beijing's market cap has increased from 7.24B to 56.99B, an increase of 687.29%. That is a compound annual growth rate of 35.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 56.99B | 36.19% |
| Dec 31, 2024 | 41.85B | -11.66% |
| Dec 29, 2023 | 47.37B | -38.44% |
| Dec 30, 2022 | 76.95B | -27.67% |
| Dec 31, 2021 | 106.40B | 12.84% |
| Dec 31, 2020 | 94.29B | 140.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 422.92B |
| WuXi AppTec | 312.71B |
| Shenzhen Mindray Bio-Medical Electronics | 269.49B |
| Sichuan Biokin Pharmaceutical | 141.91B |
| Shanghai United Imaging Healthcare | 120.18B |
| Aier Eye Hospital Group | 113.13B |
| Zhangzhou Pientzehuang Pharmaceutical., | 107.51B |
| Yunnan Baiyao Group Co.,Ltd | 100.54B |